首页> 外文期刊>Journal of the American College of Surgeons >Preliminary report of a prospective, randomized trial of underwater seal for spontaneous and iatrogenic pneumothorax.
【24h】

Preliminary report of a prospective, randomized trial of underwater seal for spontaneous and iatrogenic pneumothorax.

机译:水下密封用于自发和医源性气胸的前瞻性,随机试验的初步报告。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Management of pneumothorax has traditionally been tube thoracostomy and -20 cm H2O suction. The purpose of our study was to determine if underwater seal in iatrogenic and spontaneous pneumothoraces is safe and efficacious and if small-caliber chest tubes are appropriate for routine use in pneumothorax. STUDY DESIGN: From April 2001 through October 2003 patients with iatrogenic or spontaneous pneumothorax were enrolled in this prospective, randomized trial. Small-bore catheters were inserted. Initial management was 1 hour -20 cm H2O suction, chest radiography, and randomization into -20 cm H2O suction, -10 cm H2O suction, or underwater seal. Tubes were discontinued at 48 hours if there were no pneumothoraces and no air leaks. Those with air leaks and recurrent pneumothoraces persisting 5 days underwent pleurodesis. The primary end point was successful chest tube removal at 48 hours. The secondary end point was need for pleurodesis. RESULTS: Twenty-nine patients were analyzed. Seven were randomized to -20 cm H2O suction, 11 to -10 cm H2O suction, and 11 to underwater seal. Most (59%, 17 of 29) chest tubes were successfully removed 48 hours after placement: 57% (4 of 7) after -20 cm H2O suction, 73% (8 of 11) after -10 cm H2O suction, and 45% (5 of 11) after underwater seal (p = 0.48). Seven (24%) required pleurodesis: 29% (2 of 7) after -20 cm H2O suction, 27% (3 of 11) after -10 cm H2O suction, and 18% (2 of 11) after underwater seal (p = 0.70). CONCLUSIONS: Early underwater seal appears to be safe for treating iatrogenic and spontaneous pneumothoraces. It can achieve comparable frequencies of early chest tube removal and avoidance of operation compared with traditional management. A larger, multi-institutional study should be performed to demonstrate that pneumothorax treatment can effectively incorporate small-caliber tubes and underwater seal.
机译:背景:气胸的治疗传统上是胸腔穿刺术和-20 cm H2O抽吸。我们研究的目的是确定医源性和自发性气胸中的水下密封是否安全有效,以及小口径胸管是否适合气胸的常规使用。研究设计:从2001年4月到2003年10月,本项随机性试验纳入了医源性或自发性气胸患者。插入小口径导管。最初的处理是1小时-20 cm H2O吸力,胸部X线照相,并随机分为-20 cm H2O吸力,-10 cm H2O吸力或水下密封。如果没有气胸并且没有漏气,则在48小时时停止使用试管。那些漏气且反复出现气胸的患者持续5天进行胸膜固定术。主要终点是在48小时成功拔除胸管。次要终点是需要进行胸膜固定术。结果:分析了29例患者。七个被随机分配到-20 cm H2O吸力,11到-10 cm H2O吸力和11个水下密封。放置后48小时成功移除了大多数(59%,29个中的17个)胸管:在-20 cm H2O抽吸后57%(7个中的4个),在-10cm H2O抽吸后73%(11个中的8个)和45% (11 of 5)在水下密封之后(p = 0.48)。七(24%)需进行胸膜固定术:-20 cm H2O抽吸后为29%(7之2),-10 cm H2O抽吸后为27%(11之3),水下密封后为18%(11之2)(p = 0.70)。结论:早期水下密封似乎可安全治疗医源性和自发性气胸。与传统的治疗方法相比,它可以达到早期胸管切除的可比频率,并且避免了手术。应该进行更大的,多机构的研究,以证明气胸治疗可以有效地合并小口径管和水下密封件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号